| Inhibition of tumor necrosis factor-α reduces atherosclerosis in apolipoprotein E knockout mice L Brånén, L Hovgaard, M Nitulescu, E Bengtsson, J Nilsson, S Jovinge Arteriosclerosis, thrombosis, and vascular biology 24 (11), 2137-2142, 2004 | 665 | 2004 |
| The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor E Bengtsson, M Mörgelin, T Sasaki, R Timpl, D Heinegård, A Aspberg Journal of Biological Chemistry 277 (17), 15061-15068, 2002 | 182 | 2002 |
| The Primary Structure of a Basic Leucine-rich Repeat Protein, PRELP, Found in Connective Tissues (∗) E Bengtsson, PJ Neame, D Heinegård, Y Sommarin Journal of Biological Chemistry 270 (43), 25639-25644, 1995 | 169 | 1995 |
| Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E–deficient mice E Bengtsson, F To, K Håkansson, A Grubb, L Brånén, J Nilsson, ... Arteriosclerosis, thrombosis, and vascular biology 25 (10), 2151-2156, 2005 | 157 | 2005 |
| Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation I Rohwedder, E Montanez, K Beckmann, E Bengtsson, P Dunér, J Nilsson, ... EMBO molecular medicine 4 (7), 564-576, 2012 | 134 | 2012 |
| Chondroitin sulfate perlecan enhances collagen fibril formation: Implications for perlecan chondrodysplasias AJ Kvist, AE Johnson, M Morgelin, E Gustafsson, E Bengtsson, ... Journal of biological chemistry 281 (44), 33127-33139, 2006 | 126 | 2006 |
| Elevated plasma levels of MMP-12 are associated with atherosclerotic burden and symptomatic cardiovascular disease in subjects with type 2 diabetes I Goncalves, E Bengtsson, HM Colhoun, AC Shore, C Palombo, A Natali, ... Arteriosclerosis, thrombosis, and vascular biology 35 (7), 1723-1731, 2015 | 125 | 2015 |
| Altered metabolism distinguishes high-risk from stable carotid atherosclerotic plaques L Tomas, A Edsfeldt, IG Mollet, L Perisic Matic, C Prehn, J Adamski, ... European heart journal 39 (24), 2301-2310, 2018 | 123 | 2018 |
| Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice E Bengtsson, F To, A Grubb, K Håkansson, L Wittgren, J Nilsson, ... Atherosclerosis 180 (1), 45-53, 2005 | 123 | 2005 |
| The amino-terminal part of PRELP binds to heparin and heparan sulfate E Bengtsson, A Aspberg, D Heinegård, Y Sommarin, D Spillmann Journal of Biological Chemistry 275 (52), 40695-40702, 2000 | 90 | 2000 |
| Autophagy dysfunction and regulatory cystatin C in macrophage death of atherosclerosis W Li, N Sultana, N Siraj, LJ Ward, M Pawlik, E Levy, S Jovinge, ... Journal of cellular and molecular medicine 20 (9), 1664-1672, 2016 | 83 | 2016 |
| Inflammation and immunity in diabetic vascular complications J Nilsson, E Bengtsson, GN Fredrikson, H Björkbacka Current opinion in lipidology 19 (5), 519-524, 2008 | 77 | 2008 |
| Atheroprotective effects of Alum are associated with capture of oxidized LDL antigens and activation of regulatory T cells M Wigren, D Bengtsson, P Dunér, K Olofsson, H Björkbacka, ... Circulation Research 104 (12), e62-e70, 2009 | 76 | 2009 |
| Impaired fibrous repair: a possible contributor to atherosclerotic plaque vulnerability in patients with type II diabetes A Edsfeldt, I Gonçalves, H Grufman, M Nitulescu, P Dunér, E Bengtsson, ... Arteriosclerosis, thrombosis, and vascular biology 34 (9), 2143-2150, 2014 | 66 | 2014 |
| Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes GN Fredrikson, DV Anand, D Hopkins, R Corder, R Alm, E Bengtsson, ... Diabetologia 52, 1426-1433, 2009 | 66 | 2009 |
| High levels of soluble lectinlike oxidized low‐density lipoprotein receptor‐1 are associated with carotid plaque inflammation and increased risk of ischemic stroke H Markstad, A Edsfeldt, I Yao Mattison, E Bengtsson, P Singh, M Cavalera, ... Journal of the American Heart Association 8 (4), e009874, 2019 | 58 | 2019 |
| Elevated markers of death receptor-activated apoptosis are associated with increased risk for development of diabetes and cardiovascular disease IY Mattisson, H Björkbacka, M Wigren, A Edsfeldt, O Melander, ... EBioMedicine 26, 187-197, 2017 | 57 | 2017 |
| Animal models of diabetic macrovascular complications: key players in the development of new therapeutic approaches SE Heinonen, G Genové, E Bengtsson, T Hübschle, L Åkesson, K Hiss, ... Journal of diabetes research 2015 (1), 404085, 2015 | 54 | 2015 |
| Cystatin C and cathepsins in cardiovascular disease E Bengtsson, J Nilsson, S Jovinge Front Biosci 13 (3), 5780-5786, 2008 | 53 | 2008 |
| IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice PT Mantani, P Dunér, E Bengtsson, R Alm, I Ljungcrantz, I Söderberg, ... PloS one 10 (1), e0117255, 2015 | 51 | 2015 |
